Asia buys QCOR 93.67: Questcor Pharmaceuticals Stock Rating Lowered by Oppenheimer (QCOR)
Questcor Pharmaceuticals (NASDAQ:QCOR) was downgraded by Oppenheimer from an âoutperformâ rating to a âmarket performâ rating in a research note issued on Friday, TheFlyOnTheWall.com reports. They currently have a $86.00 target price on the stock. ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home